Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 7/20 | 0.53 |
| ▸ | HTR3E | A5X5Y0 | 4/20 | 0.53 |
| ▸ | HTR3B | O95264 | 4/20 | 0.53 |
| ▸ | HTR3A | P46098 | 4/20 | 0.53 |
| ▸ | HTR3D | Q70Z44 | 4/20 | 0.53 |
| ▸ | HTR3C | Q8WXA8 | 4/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.53 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.48 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6675497 | 1.00 | ADRB1 (0.53) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL27862519 | 0.86 | ALDH1A1 (0.47) | NCF1ALDH1A1KDM4ETSHR | |
| SCHEMBL1758061 | 0.83 | ADRB1 (0.55) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL5134023 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNAUSP2TSHR | |
| SCHEMBL11117970 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNAUSP2TSHR | |
| SCHEMBL5570604 | 0.79 | ADRB1 (0.77) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL6675494 | 0.78 | CYP3A4 (0.35) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL300437 | 0.77 | ADRB1 (0.62) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL3318505 | 0.77 | ADRB1 (0.57) | ADRB1HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL12298704 | 0.77 | ADRB1 (0.57) | ADRB1HTR3EHTR3BHTR3AHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | claimed |
| EP-1432704-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES, LTD. (IN) | 2004-06-30 | — | — | EP | claimed |
| WO-2003027103-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-03 | — | — | WO | claimed |
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | disclosed |
| EP-1432704-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES, LTD. (IN) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003027103-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | ERG28, CYP11B1, CYP2E1 | ADRB1 2635/4885HTR3E 3924/4885HTR3B 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.